20 June 2013
Keywords: merck, co, wins, male, label, fosamax, food
Article | 05 October 2000
The US Food and Drug Administration has approved an additionalindication for Merck & Co's Fosamax (alendronate), for use in men with
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 October 2000
4 October 2000
19 June 2013
© 2013 thepharmaletter.com